Role of 18F-FDG PET in stage IV thyroid cancer with positive 131I whole body scan.

被引：0
|
作者：
Piccardo, A. [1 ]
Morbelli, S. [1 ]
Bianchi, P. [1 ]
Barbera, F. [1 ]
Villavecchia, G. [1 ]
Cabria, M. [1 ]
机构：
[1] Osped Galliera, Genoa, Italy
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2007年 / 34卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：S198 / S198
页数：1
相关论文
共 50 条
  • [21] 99mTc-EDDA/HYNIC-TOC and 18F-FDG in thyroid cancer patients with negative 131I whole-body scans
    Gabriel, M
    Froehlich, F
    Decristoforo, C
    Ensinger, C
    Donnemiller, E
    von Guggenberg, E
    Heute, D
    Moncayo, R
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2004, 31 (03) : 330 - 341
  • [22] 99mTc-EDDA/HYNIC-TOC and 18F-FDG in thyroid cancer patients with negative 131I whole-body scans
    Michael Gabriel
    Franz Froehlich
    Clemens Decristoforo
    Christian Ensinger
    Eveline Donnemiller
    Elisabeth von Guggenberg
    Dirk Heute
    Roy Moncayo
    European Journal of Nuclear Medicine and Molecular Imaging, 2004, 31 : 330 - 341
  • [23] False-positive 131I whole-body scan and shrinkage of a pulmonary aspergilloma under 131I therapy in a patient with thyroid cancer
    Manka-Waluch, A
    Palmedo, H
    Tasci, S
    Biersack, HJ
    Bucerius, J
    THYROID, 2006, 16 (02) : 197 - 198
  • [24] Is it practical and cost effective to detect differentiated thyroid carcinoma metastases by 18F-FDG PET/CT, by 18F-FDG SPET/CT or by 131I SPET/CT?
    He, Xinjia
    Wang, Xucai
    Yu, Jinming
    Ma, Chao
    HELLENIC JOURNAL OF NUCLEAR MEDICINE, 2015, 18 (01): : 2 - 4
  • [25] 131I whole-body scan or 18FDG PET/CT for patients with elevated thyroglobulin and negative ultrasound?
    Treglia G.
    Bertagna F.
    Piccardo A.
    Giovanella L.
    Clinical and Translational Imaging, 2013, 1 (3) : 175 - 183
  • [26] Risk factors and stratification for recurrence of patients with differentiated thyroid cancer, elevated thyroglobulin and negative I-131 whole-body scan, by restaging 18F-FDG PET/CT
    Okuyucu, Kursat
    Ince, Semra
    Alagoz, Engin
    Emer, Ozdes
    San, Huseyin
    Balkan, Elif
    Ayan, Asli
    Meric, Coskun
    Haymana, Cem
    Acikel, Cengizhan
    Gunalp, Bengul
    Karacalioglu, Alper Ozgur
    Arslan, Nuri
    HELLENIC JOURNAL OF NUCLEAR MEDICINE, 2016, 19 (03): : 208 - 217
  • [27] Correlation of 18F-FDG PET/CT Findings With Histopathological Results in Differentiated Thyroid Cancer Patients Who Have Increased Thyroglobulin or Antithyroglobulin Antibody Levels and Negative 131I Whole-Body Scan Results
    Ozkan, Elgin
    Aras, Gulseren
    Kucuk, N. Ozlem
    CLINICAL NUCLEAR MEDICINE, 2013, 38 (05) : 326 - 331
  • [28] Comparison of 18F-FDG PET and 99-Tc-MDP bone scan for bone metastases: Value of 18F-FDG PET in cases of equivocal bone scan.
    Kang, WJ
    Chung, JK
    So, Y
    Jeong, JM
    Lee, DS
    Lee, MC
    JOURNAL OF NUCLEAR MEDICINE, 2003, 44 (05) : 377P - 377P
  • [29] 18F-FDG-PET-CT in patients with differentiated thyroid carcinoma, elevated thyroglobulin and negative 131I scan
    Mendez, D. R.
    Rodado, S.
    Santos, I.
    Hernandez, I.
    Couto, R.
    Marin, M.
    Coronado, M.
    Martin Curto, L.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 : S563 - S563
  • [30] Progression free survival related to 18F-FDG PET/CT uptake and 131I uptake in lung metastases of differentiated thyroid cancer
    Zhu, Xiaochun
    Wu, Shuqi
    Yuan, Xueyu
    Wang, Hui
    Ma, Chao
    HELLENIC JOURNAL OF NUCLEAR MEDICINE, 2019, 22 (02): : 123 - 130
12345